Diane Hollenbaugh
Chief Scientific Officer at Bonum Therapeutics focused on developing conditionally active biologics and immuno-oncology approaches, with expertise in cytokine biology and therapeutic design.
Best podcasts with Diane Hollenbaugh
Ranked by the Snipd community
17 snips
Feb 27, 2026 • 47min
Conditionally Active Therapeutics - Dr. Neela Patel, Dr. Diane Hollenbaugh
Dr. Neela Patel, CBO at Bonum Therapeutics who leads strategy and partnerships. Dr. Diane Hollenbaugh, CSO at Bonum focused on cytokine biology and therapeutic design. They explore conditionally active biologics, reversible on/off antibody systems, mechanisms to avoid systemic toxicity, tumor microenvironment challenges, and Bonum’s stroma-targeted interferon alpha program and commercial strategy.
